Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quidel Corporation

http://www.quidel.com

Latest From Quidel Corporation

JPM 2021: EY Says Pandemic Leaves Medtech With $500Bn In M&A Firepower

EY’s M&A Firepower report predicts very active M&A activity for medtechs in 2021, driven by diagnostics and digital health, but with some headwinds remaining.

M & A Financing

FDA: Rapid Antigen COVID-19 Tests At Risk For False Positives

An alert from the agency warns that the tests, which have become widely used for their speed and portability, carry a risk of false positives.

United States Coronavirus COVID-19

Coronavirus Antigen Testing Gets Green Light In Germany

Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.

Diagnostics Germany

FDA Eager To Authorize More Rapid Antigen COVID-19 Tests

The US FDA’s diagnostics chief says the agency isn’t seeing many submissions for rapid antigen tests, but is eager to authorize them. 

Regulation Approvals
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Cytology
    • Molecular Diagnostics & Genetic Testing
    • Therapeutic Drug Monitoring
  • Other Names / Subsidiaries
    • AnDiaTec
    • BioHelix Corporation
    • Diagnostic Hybrids, Inc.
UsernamePublicRestriction

Register